DK107093C - Fremgangsmåde til fremstilling af lactonen af ω-(3-oxo-16β-hydroxy-Δ<4>-androsten-16α-yl)- eller ω-(3-oxo-17β-hydroxy-Δ<4>-androsten-17α-yl)-propionsyre. - Google Patents

Fremgangsmåde til fremstilling af lactonen af ω-(3-oxo-16β-hydroxy-Δ<4>-androsten-16α-yl)- eller ω-(3-oxo-17β-hydroxy-Δ<4>-androsten-17α-yl)-propionsyre.

Info

Publication number
DK107093C
DK107093C DK178763AA DK178763A DK107093C DK 107093 C DK107093 C DK 107093C DK 178763A A DK178763A A DK 178763AA DK 178763 A DK178763 A DK 178763A DK 107093 C DK107093 C DK 107093C
Authority
DK
Denmark
Prior art keywords
androsten
oxo
hydroxy
lactone
preparation
Prior art date
Application number
DK178763AA
Other languages
English (en)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR894925A external-priority patent/FR1334968A/fr
Priority claimed from FR917918A external-priority patent/FR82818E/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of DK107093C publication Critical patent/DK107093C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
DK178763AA 1962-04-18 1963-04-17 Fremgangsmåde til fremstilling af lactonen af ω-(3-oxo-16β-hydroxy-Δ<4>-androsten-16α-yl)- eller ω-(3-oxo-17β-hydroxy-Δ<4>-androsten-17α-yl)-propionsyre. DK107093C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR894925A FR1334968A (fr) 1962-04-18 1962-04-18 Nouveau procédé de préparation de lactones stéroïdes non saturées
FR917918A FR82818E (fr) 1962-12-07 1962-12-07 Nouveau procédé de préparation de lactones stéroïdes non saturées

Publications (1)

Publication Number Publication Date
DK107093C true DK107093C (da) 1967-04-24

Family

ID=26195290

Family Applications (1)

Application Number Title Priority Date Filing Date
DK178763AA DK107093C (da) 1962-04-18 1963-04-17 Fremgangsmåde til fremstilling af lactonen af ω-(3-oxo-16β-hydroxy-Δ<4>-androsten-16α-yl)- eller ω-(3-oxo-17β-hydroxy-Δ<4>-androsten-17α-yl)-propionsyre.

Country Status (4)

Country Link
CH (1) CH435262A (da)
DE (1) DE1291335B (da)
DK (1) DK107093C (da)
GB (1) GB1036086A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057542A (en) * 1976-08-30 1977-11-08 G. D. Searle & Co. Process for the preparation of 17β-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactone

Also Published As

Publication number Publication date
GB1036086A (en) 1966-07-13
CH435262A (fr) 1967-05-15
DE1291335B (de) 1969-03-27

Similar Documents

Publication Publication Date Title
DK117068B (da) Fremgangsmåde til fremstilling af N-1-aroylindolyleddikesyreforbindelser.
DK108864C (da) Fremgangsmåde til fremstilling af (3-aminopyrazinamido)- guanider eller syreadditionssalte deraf.
DK112032B (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy- eller -acyloxy-Δ&lt;4&gt;-estrenderivater.
DK126594B (da) Analogifremgangsmåde til fremstilling af 3-morpholino-N&lt;6&gt;-cyclohexylcarbonylsydnonimin eller syreadditionssalte deraf.
DK117632B (da) Fremgangsmåde til fremstilling af 3-alkyliden-Δ&lt;4&gt;-estrener.
DK107093C (da) Fremgangsmåde til fremstilling af lactonen af ω-(3-oxo-16β-hydroxy-Δ&lt;4&gt;-androsten-16α-yl)- eller ω-(3-oxo-17β-hydroxy-Δ&lt;4&gt;-androsten-17α-yl)-propionsyre.
DK111143B (da) Fremgangsmåde til fremstilling af sulfamylanthranilsyrer.
DK105066C (da) Fremgangsmåde til fremstilling af 3-(2-pyrrolidinyl)-indoler eller syreadditionssalte deraf.
DK109329C (da) Fremgangsmåde til fremstilling af Δ&lt;4&gt;-6α-alkyl-19-nor-pregnener.
DK106090C (da) Fremgangsmåde til fremstilling af 3-halogen-Δ&lt;5&gt;-19-nor-androstener.
DK109147C (da) Fremgangsmåde til fremstilling af salicylsyrederivater.
DK107296C (da) Fremgangsmåde til fremstilling af basiske 3,5-dimenthoxy-4-alkoxybenzoesyreestere.
DK109866C (da) Fremgangsmåde til fremstilling af 7α-methyl-Δ&lt;4&gt;-østrener.
DK97881C (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-Δ&lt;5(10)&gt;-estren.
DK114686B (da) Fremgangsmåde til fremstilling af allencarboxylsyreestere.
DK110083C (da) Fremgangsmåde til fremstilling af picolinsyrederivater.
DK117067B (da) Fremgangsmåde til fremstilling af Δ&lt;4&gt;-3-ketosteroider.
DK105336C (da) Fremgangsmåde til fremstilling af 3-oxo-17-hydroxy-13β-alkyl-Δ&lt;5(10)&gt;-gonener.
DK103077C (da) Fremgangsmåde til fremstilling af 4-hydroxyphenyl-4-carbalkoxy-piperidinderivater eller syreadditionssalte deraf.
DK104171C (da) Fremgangsmåde til fremstilling af morfantridinderivater eller syreadditionssalte heraf.
DK103124C (da) Fremgangsmåde til fremstilling af dihydroxyphenyleddikesyreamiderivater.
DK104300C (da) Fremgangsmåde til fremstilling af 18-α-glycyrrhetinsyre.
DK106670C (da) Fremgangsmåde til fremstilling af Δ&lt;3&gt;-17β-hydroxy-17α-methyl-5α-androsten eller estere deraf.
DK105868C (da) Fremgangsmåde til fremstilling af Δ&lt;4&gt;-3-keto-6α-alkyl-19-nor-pregnener eller estere deraf.
DK109808C (da) Fremgangsmåde til fremstilling af N-methylaminoethyl-2-methylbenzhydrylether- eller syreadditionssalte heraf.